9.6661
Adapthealth Corp stock is traded at $9.6661, with a volume of 748.47K.
It is down -0.05% in the last 24 hours and down -7.86% over the past month.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.
See More
Previous Close:
$9.67
Open:
$9.51
24h Volume:
748.47K
Relative Volume:
0.69
Market Cap:
$1.31B
Revenue:
$3.26B
Net Income/Loss:
$79.35M
P/E Ratio:
17.74
EPS:
0.545
Net Cash Flow:
$213.17M
1W Performance:
+6.44%
1M Performance:
-7.86%
6M Performance:
+1.63%
1Y Performance:
-7.42%
Adapthealth Corp Stock (AHCO) Company Profile
Name
Adapthealth Corp
Sector
Industry
Phone
610-424-4515
Address
555 EAST NORTH LANE, CONSHOHOCKEN, PA
Compare AHCO vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
AHCO
Adapthealth Corp
|
9.67 | 1.31B | 3.26B | 79.35M | 213.17M | 0.545 |
|
ABT
Abbott Laboratories
|
110.84 | 196.53B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
369.80 | 146.14B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
92.52 | 122.74B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
71.95 | 107.15B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
83.39 | 49.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Adapthealth Corp Stock (AHCO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-24 | Downgrade | Jefferies | Buy → Hold |
| Nov-08-23 | Downgrade | BofA Securities | Neutral → Underperform |
| May-10-23 | Downgrade | Deutsche Bank | Buy → Hold |
| May-10-23 | Downgrade | Stifel | Buy → Hold |
| May-09-23 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Jul-14-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Apr-13-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-18-21 | Initiated | Truist | Buy |
| Jan-26-21 | Initiated | BofA Securities | Buy |
| Dec-10-20 | Initiated | UBS | Buy |
| Aug-10-20 | Initiated | Canaccord Genuity | Buy |
| Jul-01-20 | Resumed | SVB Leerink | Outperform |
| Jun-09-20 | Initiated | RBC Capital Mkts | Outperform |
| Jan-31-20 | Initiated | Stifel | Buy |
| Jan-07-20 | Initiated | Jefferies | Buy |
| Dec-11-19 | Initiated | SVB Leerink | Outperform |
| Dec-10-19 | Initiated | Deutsche Bank | Buy |
View All
Adapthealth Corp Stock (AHCO) Latest News
Vanguard Group Inc. Has $100.93 Million Stock Holdings in AdaptHealth Corp. $AHCO - MarketBeat
Unpacking Q4 Earnings: AdaptHealth (NASDAQ:AHCO) In The Context Of Other Senior Health, Home Health & Hospice Stocks - Finviz
AdaptHealth at J.P. Morgan Conference: Expanding Sleep Apnea Market - Investing.com
AdaptHealth Conference: CFO Details CPAP Recurring Revenue, Faster Setups, and Capitated Contract Growth - Yahoo Finance
AdaptHealth Corp. (AHCO) Stock Analysis: Exploring a 33.56% Potential Upside in the Medical Devices Sector - DirectorsTalk Interviews
Segall Bryant & Hamill LLC Cuts Stock Position in AdaptHealth Corp. $AHCO - MarketBeat
AdaptHealth Resets Earnings As Capitated Contract And Debt Raise Execution Risk - Yahoo Finance
Assessing AdaptHealth (AHCO) Valuation As Shares Struggle And A Large Capitated Contract Shapes Expectations - Sahm
Insider Buying: Rew Richard W. II Acquires Shares in AdaptHealth Corp (AHCO) - GuruFocus
Why AdaptHealth (AHCO) Is Down 9.7% After 2025 Loss, Impairment And 2026 Guidance Update – And What’s Next - simplywall.st
AHCO: Leerink Partners Lowers Price Target for AdaptHealth | AHC - GuruFocus
Leerink cuts AdaptHealth stock price target on 2025 earnings decline By Investing.com - Investing.com Nigeria
Leerink cuts AdaptHealth stock price target on 2025 earnings decline - Investing.com South Africa
HALPER SADEH LLC ENCOURAGES ADAPTHEALTH CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - Morningstar
AdaptHealth Shares Appear Oversold After Q4 Results, Outlook, RBC Says - marketscreener.com
AdaptHealth stock rating maintained at Outperform by RBC Capital - Investing.com Australia
Sentiment Recap: Can AdaptHealth Corp lead its sector in growthJuly 2025 Movers & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Volatility Watch: Is ProPetro Holding Corp benefiting from innovation trends2025 Stock Rankings & Weekly High Conviction Ideas - baoquankhu1.vn
AdaptHealth Corp. (NASDAQ:AHCO) Q4 2025 Earnings Call Transcript - Insider Monkey
Deutsche Bank Adjusts AdaptHealth Price Target to $9.50 From $10.50, Maintains Hold Rating - marketscreener.com
AdaptHealth Reports Q4 Earnings Beat Expectations - Intellectia AI
AdaptHealth Corp. (AHCO) Stock Analysis: A 30% Upside Potential Offers an Attractive Opportunity - DirectorsTalk Interviews
AdaptHealth (AHCO) Q4 Loss Of US$100 Million Tests Bullish Profitability Narrative - simplywall.st
AdaptHealth Corp. (NASDAQ:AHCO) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Decoding AdaptHealth Corp (AHCO): A Strategic SWOT Insight - GuruFocus
AdaptHealth Q4 2025 Results: Revenue Beat Overshadowed by Loss, Stock DropsNews and Statistics - IndexBox
AdaptHealth (AHCO) Q4 2025 Earnings Transcript - AOL.com
Earnings call transcript: AdaptHealth Q4 2025 misses EPS forecast By Investing.com - Investing.com UK
AdaptHealth Corp. SEC 10-K Report - TradingView
AdaptHealth Corp. Q4 2025 Earnings Call Summary - Yahoo Finance
RSI Alert: AdaptHealth (AHCO) Now Oversold - Nasdaq
AdaptHealth Corp (AHCO) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansions - GuruFocus
Why AdaptHealth (AHCO) Stock Is Nosediving - Finviz
Adapthealth earnings missed by $1.12, revenue topped estimates - Investing.com South Africa
AdaptHealth outlines 6%–8% revenue growth for 2026 as new capitated contract ramps up - MSN
AdaptHealth Corp. Experiences Evaluation Revision Amid Positive Market Indicators and Performance Trends - Markets Mojo
AdaptHealth Reports Strong Q4 2025 Earnings and Strategic Growth - Intellectia AI
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
AdaptHealth Q4 2025 slides: $128M impairment overshadows revenue beat - Investing.com
AdaptHealth Corp. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:AHCO) 2026-02-24 - Seeking Alpha
AdaptHealth Q4 Earnings Call Highlights - Yahoo Finance
AdaptHealth (NASDAQ:AHCO) Shares Down 14.2% on Disappointing Earnings - MarketBeat
Earnings call transcript: AdaptHealth Q4 2025 misses EPS forecast - Investing.com Nigeria
AdaptHealth Q4 2025 slides: $128M impairment overshadows revenue beat By Investing.com - Investing.com South Africa
AdaptHealth Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Adapthealth Corp reports results for the quarter ended December 31Earnings Summary - TradingView
AdaptHealth reports fourth quarter earnings miss By Investing.com - Investing.com Canada
AdaptHealth Corp. (AHCO) Lags Q4 Earnings Estimates - Yahoo Finance
AdaptHealth (NASDAQ:AHCO) Delivers Unexpected Q4 CY2025 Revenue Results - Bitget
AdaptHealth (NASDAQ:AHCO) Surprises With Q4 CY2025 Sales - Finviz
AdaptHealth reports fourth quarter earnings miss - Investing.com India
Adapthealth Corp Stock (AHCO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Adapthealth Corp Stock (AHCO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Rew Richard W. II | CLO and General Counsel |
Feb 26 '26 |
Buy |
8.91 |
5,000 |
44,550 |
107,097 |
| Williams David Solomon III | Director |
Dec 04 '25 |
Sale |
9.43 |
5,000 |
47,150 |
45,045 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):